BzATP triethylammonium salt

CAS No. 112898-15-4

BzATP triethylammonium salt( —— )

Catalog No. M23322 CAS No. 112898-15-4

BzATP triethylammonium salt is a P2X7 receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 170 In Stock
5MG 92 In Stock
10MG 147 In Stock
25MG 245 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BzATP triethylammonium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    BzATP triethylammonium salt is a P2X7 receptor agonist.
  • Description
    BzATP triethylammonium salt is a P2X7 receptor agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    P2 Receptor
  • Recptor
    P2X7
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112898-15-4
  • Formula Weight
    1018.96
  • Molecular Formula
    C24H24N5O15P3·C18H45N3
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:<5mM
  • SMILES
    O[C@H]1[C@H](N2C=NC3=C2N=CN=C3N)O[C@H](COP(OP(OP([O-])(O)=O)(O)=O)(O)=O)[C@H]1OC(C4=CC=C(C(C5=CC=CC=C5)=O)C=C4)=O.[NH4+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ticagrelor metabolit...

    Ticagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor.

  • RO3

    RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor.

  • APY29

    APY29 is an allosteric modulator of IRE1α; inhibits IRE1α autophosphorylation (IC50 = 280 nM) and activates IRE1α RNase activity.